Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/12/1999 | EP0915088A1 D-Proline derivatives |
05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives |
05/12/1999 | EP0914605A1 Molecular model for vla-4 inhibitors |
05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
05/12/1999 | EP0914321A1 Indole derivatives for the treatment of osteoporosis |
05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
05/12/1999 | EP0914130A2 Novel anti-viral compounds |
05/12/1999 | EP0914128A1 Formulation and method for treating congestive heart failure |
05/12/1999 | CN1216541A N-3 substituted pyrimidin-4-ones with all antagonistic activity |
05/12/1999 | CN1043344C New heterocyclic compounds, preparing method, pharmaceutical composition and use |
05/11/1999 | US5902819 Triazole derivatives |
05/11/1999 | US5902813 Modulators of the benzodiaxepine receptor ot the gamma-butyric acid(a) receptor complex; anxiolytic, antiepileptic and -convulsant agents; sleep and memory disorders |
05/06/1999 | WO1999021851A1 Sulfamoyl compounds and agricultural or horticultural bactericide |
05/06/1999 | WO1999021848A2 Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
05/06/1999 | WO1999021840A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
05/06/1999 | WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
05/06/1999 | EP0912560A1 Indole derivatives for the treatment of osteoporosis |
05/06/1999 | EP0912559A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
05/06/1999 | EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
05/06/1999 | EP0912557A1 Oxindole derivatives |
05/06/1999 | EP0912553A1 BENZO[g]QUINOLINE DERIVATIVES |
05/06/1999 | EP0912542A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex |
05/06/1999 | EP0912520A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
05/06/1999 | EP0912512A1 Sulphonamide derivatives and their use in the treatment of cns disorders |
05/06/1999 | EP0912465A1 Improved lithium and amine dissolving metal reduction |
05/06/1999 | EP0794953B1 Quinazoline derivatives |
05/06/1999 | EP0772604B1 Triazole compounds and their use as dopamine-d3-ligands |
05/06/1999 | EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation |
05/06/1999 | EP0623114B1 Phenyl imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
05/06/1999 | DE19748470A1 Carbamoylphenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Carbamoylphenylsulfonylharnstoffe, processes for their preparation and their use as herbicides and plant growth regulators |
05/05/1999 | CN1216042A Carboxylic acid derivs, their production and use |
05/05/1999 | CN1216041A Carboxylic acid derivs, their production and use |
05/04/1999 | US5900428 Pharmacological use of AII-receptor antagonists |
04/29/1999 | WO1999020622A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
04/29/1999 | WO1999020278A1 Use of moxonidine for the treatment of depression |
04/29/1999 | CA2306982A1 Use of moxonidine for the treatment of depression |
04/28/1999 | EP0911329A1 3-Substituted arylpyrazole derivatives |
04/28/1999 | EP0910563A1 Integrin receptor antagonists |
04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
04/28/1999 | CN1215400A Piperazine and piperidine compounds |
04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
04/28/1999 | CN1215054A Bychclic fibrinogen antagonists |
04/28/1999 | CN1043141C Heterocyclic amines compound, its preparation process, medicinal composition containing same and medical use thereof |
04/27/1999 | CA1340513C Antitumor and antiviral alkaloids |
04/22/1999 | WO1999019338A1 Inhibitors of nucleoside metabolism |
04/22/1999 | WO1999019304A2 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
04/22/1999 | WO1999019303A1 Pyrazole derivatives |
04/22/1999 | WO1999019301A1 Piperazine compounds and medicinal use thereof |
04/22/1999 | WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders |
04/22/1999 | WO1999019297A1 Synthesis of azetidine derivatives |
04/22/1999 | WO1999018967A1 Analgesic compositions |
04/22/1999 | WO1999018951A1 Inhibitors of farnesyl protein transferase |
04/22/1999 | WO1999018942A1 Use of csaidtm compounds for the management of uterine contractions |
04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
04/22/1999 | CA2316296A1 Use of csaidtm compounds for the management of uterine contractions |
04/22/1999 | CA2306811A1 Piperazine compounds and medicinal use thereof |
04/22/1999 | CA2304979A1 Pyrazole derivatives having a calcium release-activated calcium channel inhibitory effect |
04/22/1999 | CA2304473A1 Inhibitors of farnesyl protein transferase |
04/22/1999 | CA2301800A1 Thioalkyl alpha substituted pyrimidine compounds |
04/21/1999 | EP0909271A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
04/21/1999 | CN1214685A Inhibitors of farnesyl protein transferase |
04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
04/21/1999 | CN1043041C Ethers derivatives containing heterocyclic radical and insecticide using the same as active composition |
04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
04/15/1999 | WO1999018073A1 Azetidinone derivatives for the treatment of hcmv infections |
04/15/1999 | WO1999018072A1 Azetidinone derivatives for the treatment of hcmv infections |
04/15/1999 | WO1999017778A1 α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS |
04/15/1999 | WO1999017777A1 Inhibitors of prenyl-protein transferase |
04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
04/14/1999 | EP0907650A1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines |
04/14/1999 | EP0907644A1 Pharmaceutical preparation |
04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
04/14/1999 | EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
04/14/1999 | CN1214045A Process for aminocarbonylation of benzazepines and benzodiazepines |
04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
04/14/1999 | CN1214041A Sulfonated amino acid derivatives and metalloproteinase inhibitors contg. same |
04/13/1999 | CA1340492C Novel naphthyridine-and quinoline-carboxylic acids as bacterial agents |
04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
04/08/1999 | WO1999016437A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
04/07/1999 | EP0906311A1 N-sulfonylimidazoles used as fungicides |
04/07/1999 | EP0906306A1 Pyrrolyl quinoxalindiones, their production and use as ampa receptor antagonists |
04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
04/07/1999 | EP0796297B1 Methine dyes based one formylaminopyridones |
04/07/1999 | EP0659181B1 Sulfonamide inhibitors of hiv-aspartyl protease |
04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
04/07/1999 | CN1213369A Quinoxalinediones |
04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
04/06/1999 | US5891906 Antiinflammatory agents using benzoditerpenes and benzolactams |
04/06/1999 | US5891902 Osteoporosis |